Acetylcarnitine
- Generic Name
- Acetylcarnitine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C9H17NO4
- CAS Number
- 3040-38-8
- Unique Ingredient Identifier
- 6DH1W9VH8Q
- Background
Acetylcarnitine is an investigational drug in the United states, Italy, United Kingdom, China, Israel, and Norway, and it is approved in Italy, Portugal, Argentina, Chile, Philippines, Australia, and India. Acetylcarnitine can be synthesized, but it is also naturally found in adequate amounts in healthy humans. In human plasma and tissues, acetylcarnitine is...
- Indication
Acetylcarnitine is not approved for any indication in the United states and Canada, but it is approved and indicated in Italy for cerebrovascular disorders, mental function disorders, peripheral nerve disorders, diabetic neuropathy, and nutritional supplementation; Portugal for mental function disorders; Argentina for cerebral vasculopathy, nutritional suppl...
- Associated Conditions
- Peripheral nerve lesion
- Associated Therapies
- -
Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS
- Conditions
- Interventions
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2024-12-05
- Target Recruit Count
- 246
- Registration Number
- NCT06126315
Preventive Effect of Acetyl-L-carnitine on Oxaliplatin-induced Peripheral Neuropathy
- Conditions
- Interventions
- First Posted Date
- 2022-11-01
- Last Posted Date
- 2022-11-01
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 100
- Registration Number
- NCT05601479
- Locations
- 🇨🇳
Nanfang Hospital, Southern Medical University/The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China
Enhancing the Effects of Adolescent Alcohol Treatment With Acetyl-L-Carnitine
- Conditions
- Interventions
- First Posted Date
- 2022-05-02
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- Brown University
- Target Recruit Count
- 50
- Registration Number
- NCT05355311
- Locations
- 🇺🇸
Brown University Center for Alcohol and Addiction Studies, Providence, Rhode Island, United States
Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease
- Conditions
- Interventions
- First Posted Date
- 2016-11-04
- Last Posted Date
- 2021-04-14
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 265
- Registration Number
- NCT02955706
- Locations
- 🇰🇷
Konkuk university medical center, Seoul, Korea, Republic of
A Pilot Study Investigating the Effects of Acetyl-L-Carnitine and Vincristine-Induced Neuropathy in Pediatric Patients With ALL
- Conditions
- Interventions
- First Posted Date
- 2015-11-06
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Indiana University
- Target Recruit Count
- 8
- Registration Number
- NCT02598622
Acetyl-L-Carnitine Reduces Perceived Work Stress and Improves Work Ability and Work Performance in Hepatic Encephalopathy
- Conditions
- Interventions
- First Posted Date
- 2014-06-24
- Last Posted Date
- 2014-06-24
- Lead Sponsor
- University of Catania
- Target Recruit Count
- 94
- Registration Number
- NCT02173132
- Locations
- 🇮🇹
University of Catania, Catania, Italy
Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome
- Conditions
- Interventions
- First Posted Date
- 2014-05-16
- Last Posted Date
- 2017-10-27
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 20
- Registration Number
- NCT02141035
- Locations
- 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
🇨🇦Glenrose Hosptial, Edmonton, Alberta, Canada
🇨🇦Royal Alexandra Hospital, Edmonton, Alberta, Canada
An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia
- First Posted Date
- 2013-08-13
- Last Posted Date
- 2016-04-12
- Lead Sponsor
- University of South Florida
- Target Recruit Count
- 20
- Registration Number
- NCT01921868
- Locations
- 🇺🇸
University of South Florida, Tampa, Florida, United States
Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin
- First Posted Date
- 2013-08-01
- Last Posted Date
- 2013-08-01
- Lead Sponsor
- University of Catania
- Registration Number
- NCT01913964
Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance.
- Conditions
- Interventions
- First Posted Date
- 2013-07-26
- Last Posted Date
- 2013-07-26
- Lead Sponsor
- University of Catania
- Target Recruit Count
- 62
- Registration Number
- NCT01909557
- Locations
- 🇮🇹
University of Catania, Cannizzaro Hospital, Catania, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.